Impact of initiation of targeted therapy on the use of psoriatic arthritis-related treatments and healthcare consumption: a cohort study of 9793 patients from the French health ins... by Pascal Claudepierre, Laura Pina Vegas, Emilie Sbidian, Siham Iggui

Get full text

Risk of serious infection associated with different classes of targeted therapies used in psoriatic arthritis: a nationwide cohort study from the French Health Insurance Database (... by Pascal Claudepierre, Léa Bastard, Laura Pina Vegas, Emilie Sbidian, Laetitia Penso

Get full text

Impact of the time of initiation and line of biologic therapy on the retention rate of secukinumab in axial spondyloarthritis (axSpA): data from the French multicentre retrospectiv... by Maxime Dougados, Pascal Claudepierre, Philippe Goupille, Alain Saraux, Anne Tournadre, Daniel Wendling, Cédric Lukas, Adeline Ryussen-Witrand, Emilie Desfleurs, Audrey Lardy-Cleaud

Get full text

Diagnosis challenges in inception cohorts in axial spondyloarthritis: the case of the French national DESIR cohort by Francis Berenbaum, Maxime Dougados, Laure Gossec, Anna Molto, Pascal Claudepierre, Adeline Ruyssen-Witrand, Bernard Combe, Alain Saraux, Chris Serrand, Daniel Wendling, Sandrine Alonso

Get full text

When generative artificial intelligence answers to Google Trends about spondyloarthritis: what does a French expert panel think about it? by Damien Loeuille, Pascal Claudepierre, Corinne Miceli-Richard, Renaud Felten, Emmanuelle Dernis, Hubert Marotte, Philippe Goupille, Athan Baillet, Anne Tournadre, Maxime Breban, Thierry Lequerre, Daniel Wendling, Cédric Lukas, Thao Pham, Félicie Costantino, Clément Prati, Adeline Ryussen-Witrand, Olivier Fakih, Frank Verhoeven, Laura Pina Vegas

Get full text